نتایج جستجو برای: transmission blocking vaccine

تعداد نتایج: 397418  

Journal: :Archives of medical research 2006
William A Petri Omer Chaudhry R Haque Eric Houpt

The Gal/GalNAc lectin is a candidate vaccine antigen for an amebiasis vaccine due to its mediation of parasite adherence to the human intestine, because partial immunity in humans is associated with a mucosal IgA response against it, and because it is effective as a vaccine against amebic colitis in the murine model. The LecA domain of the Gal/GalNAc lectin contains neutralizing antibody epitop...

2016
T. Alex Perkins Robert C. Reiner Quirine A. ten Bosch Guido España Amit Verma Kelly A. Liebman Valerie A. Paz-Soldan John P. Elder Amy C. Morrison Steven T. Stoddard Uriel Kitron Gonzalo M. Vazquez-Prokopec Thomas W. Scott David L. Smith

Given the limited effectiveness of strategies based solely on vector control to reduce dengue virus transmission, it is expected that an effective vaccine could play a pivotal role in reducing the global disease burden of dengue. Dengvaxia® from Sanofi Pasteur recently became the first dengue vaccine to become licensed in select countries and to achieve WHO recommendation for use in certain set...

Journal: :Pathogens 2021

Background: Mosquito galactose-specific C-type lectins (mosGCTLs), such as mosGCTL-1, act ligands to facilitate the invasion of flaviviruses like West Nile virus (WNV). WNV interacts with mosGCTL-1 Aedes aegypti (Culicidae) and facilitates this virus. Nevertheless, there is no data about role a transmission-blocking vaccine candidate in Culex pipiens, most abundant Culicinae mosquito temperate ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید